These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22222880)

  • 21. FDA notifications. New labeling for N-9 products?
    AIDS Alert; 2003 Mar; 18(3):40. PubMed ID: 12635610
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of new regulations for pediatric labeling by the Food and Drug Administration.
    Buck ML
    Pediatr Nurs; 2000; 26(1):95-6. PubMed ID: 12026326
    [No Abstract]   [Full Text] [Related]  

  • 23. The new FDA pregnancy labeling requirements for drugs.
    Frederiksen MC
    J Midwifery Womens Health; 2011; 56(3):303-7. PubMed ID: 21535377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of sunscreens distributed by 2 major US retailers for meeting recommendations by the American Academy of Dermatology.
    Yazdani Abyaneh MA; Griffith RD; Falto-Aizpurua L; Nouri K
    J Am Acad Dermatol; 2014 Nov; 71(5):1011-2. PubMed ID: 25437965
    [No Abstract]   [Full Text] [Related]  

  • 25. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Mar; 64(51):13254-303. PubMed ID: 10557606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New FDA rule affects drug labeling.
    J Am Vet Med Assoc; 1998 Sep; 213(5):598. PubMed ID: 9731244
    [No Abstract]   [Full Text] [Related]  

  • 28. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1993 Jul; 270(3):302. PubMed ID: 8315763
    [No Abstract]   [Full Text] [Related]  

  • 29. Delegations of authority and organization; issuance of written notices--FDA. Final rule.
    Fed Regist; 1992 May; 57(85):18823-4. PubMed ID: 10118461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Spotlight on Sunscreen Regulation.
    Sharfstein JM
    N Engl J Med; 2015 Jul; 373(2):101-3. PubMed ID: 26154783
    [No Abstract]   [Full Text] [Related]  

  • 31. Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Nov; 64(220):62110-2. PubMed ID: 11010691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New OTC drug facts label.
    FDA Consum; 2002; 36(4):35. PubMed ID: 12184303
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug labeling changes.
    Silberstein EB
    J Nucl Med; 1998 Oct; 39(10):1831. PubMed ID: 9776300
    [No Abstract]   [Full Text] [Related]  

  • 34. Is it worth the trouble? The new policy on dissemination of information on off-label drug use under the Food and Drug Administration Modernization Act of 1997.
    Weeks EA
    Food Drug Law J; 1999; 54(4):645-65. PubMed ID: 11824459
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety-related drug labeling changes approved by FDA.
    White GG
    J Toxicol Clin Toxicol; 1998; 36(3):265-7. PubMed ID: 9678979
    [No Abstract]   [Full Text] [Related]  

  • 36. New restrictions on health claims for dietary supplements.
    King AB
    Nutrition; 1994; 10(4):358-9. PubMed ID: 8000160
    [No Abstract]   [Full Text] [Related]  

  • 37. Measuring sunscreens' ability to protect against skin cancer. Effectiveness goes beyond SPF rating.
    ;
    J Am Vet Med Assoc; 2009 Jul; 235(2):137-8. PubMed ID: 19610239
    [No Abstract]   [Full Text] [Related]  

  • 38. Panel demands FDA action to address dramatic increases in skin cancer in United States.
    Dermatol Nurs; 2009; 21(4):221. PubMed ID: 19691241
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA proposes more stringent pediatric-use labeling of prescription drug products.
    Clin Pharm; 1993 Jan; 12(1):6. PubMed ID: 8428434
    [No Abstract]   [Full Text] [Related]  

  • 40. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.